Paper · 68923

The immune response to oxidized ferredoxin. I. Specificity of the response to the amino terminal determinant.

Gregerson DS and 2 others. Immunology, 1976. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. The immune response to oxidized ferredoxin. I. Specificity of the response to the amino terminal determinant. Papers, record 68923. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68923

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: The immune response to oxidized ferredoxin. I. Specificity of the response to the amino terminal determinant.; PubMed
Journal: Immunology; PubMed
Year: 1976; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/68923/; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC1445248/; PubMed
The journal: https://conductscience.org/library/journal-index/0374672; PubMed
Citations, by iCite: 6; iCite
Relative citation ratio, by iCite: 0.16; iCite
Revised in PubMed: 2018-11-13; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Gregerson DS	D S
2	Kelly B	B
3	Levy JG	J G

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Epitopes	Major topic
Ferredoxins	Major topic
Amino Acid Sequence
Animals
Cell Migration Inhibition
Complement Fixation Tests
Guinea Pigs
Macrophage Migration-Inhibitory Factors
Peptides
Rabbits

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	5,459,532	Immunological studies on peptides from the haptenic C-terminal octapeptide of Clostridium pasteurianum ferredoxin.	Biochemistry	1970	https://conductscience.org/library/papers/5459532	PubMed
2	5,558,070	Immune response to chemically modified flagellin. II. Evidence for a fundamental relationship between humoral and cell-mediated immunity.	J Exp Med	1971	https://conductscience.org/library/papers/5558070	PubMed
3	5,688,081	Immunochemical studies on the specificity of cellular hypersensitivity. The in vitro inhibition of peritoneal exudate cell migration by cehmically defined antigens.	J Exp Med	1968	https://conductscience.org/library/papers/5688081	PubMed
4	5,799,125	Immunochemical studies on tobacco mosaic virus protein. IX. Investigations on binding and antigenic specificity of antibodies to an antigenic area of tobacco mosaic virus protein.	Biochemistry	1969	https://conductscience.org/library/papers/5799125	PubMed
5	6,026,234	A method for the quantitative modification and estimation of carboxylic acid groups in proteins.	J Biol Chem	1967	https://conductscience.org/library/papers/6026234	PubMed
6	5,439,043	Synthesis of haptenic C-terminal octapeptides of two cross-reacting bacterial ferredoxin molecules.	Biochemistry	1970	https://conductscience.org/library/papers/5439043	PubMed
7	5,409,944	Studies on the immune response to a characterized antigenic determinant of the tobacco mosaic virus protein.	J Exp Med	1970	https://conductscience.org/library/papers/5409944	PubMed
8	50,559	Two genes in the major histocompatibility complex control immune response.	Nature	1975	https://conductscience.org/library/papers/50559	PubMed
9	5,011,012	The effect of haptenic peptides from performic acid oxidized ferredoxin from Clostridium pasteurianum and protein carrier-hapten conjugates on the immune response of macrophages and lymphoid cells from animals immunized against oxidized ferredoxin.	Cell Immunol	1972	https://conductscience.org/library/papers/5011012	PubMed
10	4,997,585	Immune response to chemically modified flagellin. I. Induction of antibody tolerance to flagellin by acetoacetylated derivatives of the protein.	J Exp Med	1971	https://conductscience.org/library/papers/4997585	PubMed

1 to 10 of 30

See all 30 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMID	Title	Journal	Year	In Papers	Source
6,168,025	Function of macrophages as antigen presenting cells.	Springer Semin Immunopathol	1980	https://conductscience.org/library/papers/6168025	PubMed
1,088,421	The immune response to oxidized ferredoxin. II. Cross reactivity of cells and antisera to modified ferredoxins and the nature of the cells responding in vitro.	Immunology	1976	https://conductscience.org/library/papers/1088421	PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/68923

GET https://conductscience.org/api/papers/v1/68923/references?page=2

API reference For AI assistants